Stevanato Group S.p.A. (STVN) Stock Price

STVNStock

$22.70−1.55%52W

Market Cap$6.20B

P/E36.42x

PEG Ratio0.37

Div yield0.21%

Beta0.75

STVN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)25.97%

Price vs S&P 500 (4W)7.47%

PEG Ratio0.37

VGM Score49.84

P/E Ratio (Annual)36.42x

Indicated Dividend Yield (Annual)0.21%

P/CF (Annual)17.80x

Book Value / Share (Quarterly)$6.62

P/TBV (Annual)3.28x

Indicated Dividend (Annual)$0.07

Revenue Growth (3Y)6.44%

Cash Flow / Share (Quarterly)$-0.13

Payout Ratio (TTM)18.07%

Price vs S&P 500 (YTD)-1.27%

Gross Margin (TTM)29.94%

Net Profit Margin (TTM)10.99%

EPS (TTM)$0.58

10-Day Avg Trading Volume0.56M

EPS Excl Extra (TTM)$0.58

Revenue Growth (5Y)12.37%

EPS (Annual)$0.60

Dividend / Share (Annual)$0.06

ROI (Annual)7.15%

Gross Margin (Annual)29.60%

Net Profit Margin (5Y Avg)13.26%

Cash / Share (Quarterly)$0.40

P/E Basic Excl Extra (TTM)37.83x

Revenue Growth QoQ (YoY)7.86%

EPS Growth (5Y)13.98%

P/E Normalized (Annual)36.42x

ROA (Last FY)5.50%

Revenue Growth TTM (YoY)7.00%

EBITD / Share (TTM)$0.91

ROE (5Y Avg)12.19%

Operating Margin (TTM)16.37%

Cash Flow / Share (Annual)$0.05

P/B Ratio3.29x

P/B Ratio (Quarterly)3.06x

Net Income / Employee (Annual)$27,191

EV / Revenue (TTM)4.45x

Net Interest Coverage (TTM)20.90x

ROA (TTM)5.30%

EPS Growth QoQ (YoY)-22.70%

EV / EBITDA (TTM)25.67x

EPS Incl Extra (Annual)$0.60

Current Ratio (Annual)1.76x

Quick Ratio (Quarterly)1.08x

3-Month Avg Trading Volume0.42M

52-Week Price Return-1.55%

EV / Free Cash Flow (Annual)494.05x

P/E Incl Extra (TTM)37.83x

Revenue / Employee (TTM)$237,949

Tangible BV / Share (Quarterly)$6.46

P/S Ratio (Annual)4.29x

Asset Turnover (Annual)0.47x

52-Week High$32.68

Operating Margin (5Y Avg)17.73%

EPS Excl Extra (Annual)$0.60

CapEx CAGR (5Y)23.43%

26-Week Price Return37.22%

Quick Ratio (Annual)1.26x

13-Week Price Return24.76%

Total Debt / Equity (Annual)0.32x

Current Ratio (Quarterly)1.61x

Enterprise Value$6.37B

Revenue / Share Growth (5Y)14.12%

Asset Turnover (TTM)0.48x

Revenue / Employee (Annual)$230,363

Inventory Turnover (Annual)3.25x

Pretax Margin (Annual)15.94%

Cash / Share (Annual)$0.56

3-Month Return Std Dev37.47%

Gross Margin (5Y Avg)31.00%

Net Income / Employee (TTM)$26,140

EBITDA CAGR (5Y)13.56%

EBITDA Interim CAGR (5Y)-3.36%

ROE (Last FY)9.41%

Net Interest Coverage (Annual)19.54x

EPS Basic Excl Extra (Annual)$0.60

P/FCF (TTM)1067.61x

Receivables Turnover (TTM)2.76x

EV / Free Cash Flow (TTM)412.96x

Total Debt / Equity (Quarterly)0.29x

EPS Incl Extra (TTM)$0.58

Receivables Turnover (Annual)2.44x

ROI (TTM)6.89%

P/S Ratio (TTM)4.16x

Pretax Margin (5Y Avg)17.33%

Revenue / Share (Annual)$5.07

Tangible BV / Share (Annual)$6.20

Forward P/E26.20x

Free OCF CAGR (5Y)-28.64%

Price vs S&P 500 (52W)-19.86%

P/E Ratio (TTM)37.83x

EPS Growth TTM (YoY)0.28%

Year-to-Date Return10.69%

5-Day Price Return5.05%

EPS Normalized (Annual)$0.60

ROA (5Y Avg)7.13%

Net Profit Margin (Annual)11.79%

Month-to-Date Return12.19%

Cash Flow / Share (TTM)$1.05

EBITD / Share (Annual)$0.90

EPS Growth (3Y)-1.71%

Operating Margin (Annual)16.76%

LT Debt / Equity (Annual)0.23x

P/CF (TTM)20.48x

ROI (5Y Avg)8.81%

P/E Excl Extra (TTM)37.83x

LT Debt / Equity (Quarterly)0.20x

EPS Basic Excl Extra (TTM)$0.58

P/TBV (Quarterly)3.14x

Payout Ratio (Annual)10.54%

P/B Ratio (Annual)3.20x

Dividend / Share (TTM)$0.06

Inventory Turnover (TTM)2.94x

Pretax Margin (TTM)15.69%

Book Value / Share (Annual)$6.35

Price vs S&P 500 (13W)21.97%

Net Margin Growth (5Y)-0.12%

Dividend Yield (TTM)0.29%

Beta0.75x

P/FCF (Annual)461.07x

Revenue / Share (TTM)$5.24

ROE (TTM)8.97%

52-Week Low$15.04

vGradeD

gGradeC

mGradeB

vgmGradeC

STVN Earnings Surprise History

Q2 250.15est. 0.14

Q3 250.19est. 0.17

Q4 250.24est. 0.23

Q1 260.15est. 0.14

Q2 260.19est. 0.17

STVN Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.18

4.17

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
STVNStevanato Group S.p.A.	D	C	B	$22.70
SYKStryker Corporation	C	B	C	$330.59
MMM3M Company	C	D	B	$179.37
BSXBoston Scientific Corp.	C	B	D	$49.86
BDXBecton, Dickinson and Co.	B	D	B	$189.78
MDLNMedline Inc. Class A common stock	C	D	C	$35.64
RMDResMed Inc.	C	B	C	$236.59
DXCMDexCom, Inc.	D	B	B	$89.16
WSTWest Pharmaceutical Services, Inc.	D	C	B	$348.48
SOLVSolventum Corporation	C	C	B	$91.61
BAXBaxter International Inc.	B	D	B	$26.29
PENPenumbra, Inc.	D	C	C	$324.37
GMEDGLOBUS MEDICAL INC	B	B	C	$82.96
GKOSGlaukos Corporation	F	A	A	$181.39
PODDInsulet Corporation	C	A	D	$143.05
TFXTeleflex Incorporated	B	F	B	$140.18
MMSIMerit Medical Systems Inc	C	B	B	$91.09
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$18.92
HAEHaemonetics Corporation	C	C	A	$108.32
ICUIICU Medical Inc	C	D	B	$182.24
HTFLHeartflow, Inc. Common Stock	—	A	A	$49.89
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$123.09
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$49.00
ATRCAtriCure, Inc.	D	B	A	$48.68
UFPTUFP Technologies Inc	C	B	B	$304.21
NVCRNovoCure Limited Ordinary Shares	D	C	C	$17.62
LMATLeMaitre Vascular, Inc.	C	B	D	$78.97
INSPInspire Medical Systems, Inc.	B	B	B	$61.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$26.92
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.58
ATECAlphatec Holdings, Inc.	D	B	C	$9.33
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.70
IARTIntegra LifeSciences Holdings	B	D	C	$16.79
AORTArtivion, Inc.	C	C	C	$26.38
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$21.60
IRMDiRadimed Corporation	D	B	C	$87.87
BVSBioventus Inc. Class A Common Stock	B	C	A	$14.08
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.60
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.54
BBNXBeta Bionics, Inc. Common Stock	D	A	A	$19.34
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.55
ANGOAngioDynamics, Inc.	C	D	B	$15.95
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$24.50
MDXGMiMedx Group, Inc	C	D	C	$4.34
DCTHDelcath Systems Inc	D	B	A	$16.92
BWAYBrainsway Ltd. American Depositary Shares	F	A	C	$14.43
CERSCerus Corp	D	C	B	$2.72
TCMDTactile Systems Technology, Inc.	B	B	C	$23.58
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$16.96
NPCENeuropace, Inc. Common Stock	D	C	C	$14.16
SIShoulder Innovations, Inc.	—	B	A	$22.32

About Stevanato Group S.p.A.

Stevanato Group provides integrated drug containment, delivery, and diagnostic solutions throughout the pharmaceutical and biotechnology industries' product life cycles, spanning development, clinical, and commercial stages. The company operates through two segments: Biopharmaceutical and Diagnostic Solutions, which generates the majority of revenue, and Engineering. Stevanato derives most of its revenue from Europe, the Middle East, and Africa.